RxDoctor Payments Data

Matthew Scarlett, MD

Otolaryngology · Charleston, SCNPI 1144228438

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.6% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Medtronic at 49.1% of the total. That places this record below the midpoint for otolaryngology clinicians in SC, where the typical reported total is $1,243.

$631in general payments, 2019–2025

Across 14 payments — averaging $45.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$310
  • Neurent Medical Limited$114
  • Aerin Medical Inc.$51
  • Intersect ENT, Inc.$42
  • Merck$35
  • Sanofi$25
  • plus $54 from 3 others
$32,760in ownership & investment interests, 2019–2025

Across 7 payments — averaging $4680.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • The North Carolina Mutual Wholesale Drug Company Inc$33K

What the payments were for

  • Travel & lodging$223%
  • Food & beverage$60997%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$631 in reported general payments places this provider in the 35th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$206,524
Medicare patients
546
Services billed
2,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl96$2,088
Fluocinolone Acetonide Oil36$1,992
Ipratropium Bromide74$1,872
Fluticasone Propionate80$1,184
Famotidine77$857
Mupirocin34$204
Cefdinir14$194
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$187
Montelukast Sodium17$111
Prednisone43$102
Ondansetron Hcl23$70
Omeprazole15$39

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →